Literature DB >> 33388899

Muscle-Bone Crosstalk in Chronic Kidney Disease: The Potential Modulatory Effects of Exercise.

Diogo V Leal1, Aníbal Ferreira2,3, Emma L Watson4, Kenneth R Wilund5, João L Viana6.   

Abstract

Chronic kidney disease (CKD) is a prevalent worldwide public burden that increasingly compromises overall health as the disease progresses. Two of the most negatively affected tissues are bone and skeletal muscle, with CKD negatively impacting their structure, function and activity, impairing the quality of life of these patients and contributing to morbidity and mortality. Whereas skeletal health in this population has conventionally been associated with bone and mineral disorders, sarcopenia has been observed to impact skeletal muscle health in CKD. Indeed, bone and muscle tissues are linked anatomically and physiologically, and together regulate functional and metabolic mechanisms. With the initial crosstalk between the skeleton and muscle proposed to explain bone formation through muscle contraction, it is now understood that this communication occurs through the interaction of myokines and osteokines, with the skeletal muscle secretome playing a pivotal role in the regulation of bone activity. Regular exercise has been reported to be beneficial to overall health. Also, the positive regulatory effect that exercise has been proposed to have on bone and muscle anatomical, functional, and metabolic activity has led to the proposal of regular physical exercise as a therapeutic strategy for muscle and bone-related disorders. The detection of bone- and muscle-derived cytokine secretion following physical exercise has strengthened the idea of a cross communication between these organs. Hence, this review presents an overview of the impact of CKD in bone and skeletal muscle, and narrates how these tissues intrinsically communicate with each other, with focus on the potential effect of exercise in the modulation of this intercommunication.

Entities:  

Keywords:  Bone; Ckd; Exercise; Muscle; Myokines; Osteokines

Year:  2021        PMID: 33388899     DOI: 10.1007/s00223-020-00782-4

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  156 in total

Review 1.  Clinical relevance of sarcopenia in chronic kidney disease.

Authors:  Ranjani N Moorthi; Keith G Avin
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-05       Impact factor: 2.894

Review 2.  Physical inactivity: a risk factor and target for intervention in renal care.

Authors:  Dorien M Zelle; Gerald Klaassen; Edwin van Adrichem; Stephan J L Bakker; Eva Corpeleijn; Gerjan Navis
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

Review 3.  Chronic kidney disease: a clinical model of premature aging.

Authors:  Peter Stenvinkel; Tobias E Larsson
Journal:  Am J Kidney Dis       Date:  2013-01-26       Impact factor: 8.860

Review 4.  Chronic kidney disease and premature ageing.

Authors:  Jeroen P Kooman; Peter Kotanko; Annemie M W J Schols; Paul G Shiels; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2014-10-07       Impact factor: 28.314

5.  Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  S Moe; T Drüeke; J Cunningham; W Goodman; K Martin; K Olgaard; S Ott; S Sprague; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

Review 6.  Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease.

Authors:  Keith G Avin; Ranjani N Moorthi
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

Review 7.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Authors:  Ron T Gansevoort; Ricardo Correa-Rotter; Brenda R Hemmelgarn; Tazeen H Jafar; Hiddo J Lambers Heerspink; Johannes F Mann; Kunihiro Matsushita; Chi Pang Wen
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

Review 8.  Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.

Authors:  Ana Pimentel; Pablo Ureña-Torres; M Carola Zillikens; Jordi Bover; Martine Cohen-Solal
Journal:  Kidney Int       Date:  2017-09-28       Impact factor: 10.612

9.  Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors.

Authors:  Viviane Angelina de Souza; Dílmerson Oliveira; Sérgio Ribeiro Barbosa; José Otávio do Amaral Corrêa; Fernando Antônio Basile Colugnati; Henrique Novais Mansur; Natália Maria da Silva Fernandes; Marcus Gomes Bastos
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

10.  Sarcopenia in CKD: a roadmap from basic pathogenetic mechanisms to clinical trials.

Authors:  Alberto Ortiz; Maria Dolores Sanchez-Niño
Journal:  Clin Kidney J       Date:  2019-02-05
View more
  6 in total

1.  Bone in CKD, a Fascinating Evolving Topic.

Authors:  J Cannata-Andía; N Carrillo-López; A Ferreira
Journal:  Calcif Tissue Int       Date:  2021-04-06       Impact factor: 4.333

Review 2.  Skeletal Muscle Complications in Chronic Kidney Disease.

Authors:  Ashley D Troutman; Eliott Arroyo; Kenneth Lim; Ranjani N Moorthi; Keith G Avin
Journal:  Curr Osteoporos Rep       Date:  2022-09-23       Impact factor: 5.163

3.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

Review 4.  The Effect of Nutrition and Exercise on Body Composition, Exercise Capacity, and Physical Functioning in Advanced CKD Patients.

Authors:  Maryam Ekramzadeh; Domenico Santoro; Joel D Kopple
Journal:  Nutrients       Date:  2022-05-20       Impact factor: 6.706

5.  Renal failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice.

Authors:  Naoyuki Kawao; Miku Kawaguchi; Takashi Ohira; Hiroki Ehara; Yuya Mizukami; Yoshimasa Takafuji; Hiroshi Kaji
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-07       Impact factor: 12.063

6.  Association between the appendicular lean mass index or handgrip strength and bone mineral density in patients undergoing peritoneal dialysis.

Authors:  Seok Hui Kang; A Young Kim; Jun Young Do
Journal:  Int J Med Sci       Date:  2022-08-08       Impact factor: 3.642

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.